Dyspnea, Minor Bleeds Led Causes for Stopping Ticagrelor in Trial

"As clinicians we shouldn't underestimate the impact on patients of nosebleeds and bruising," said a PEGASUS TIMI 54 researcher, so before treatment patients should hear about even nonmajor risks.